Industry veterans of managed care solutions, healthcare biotech, and transplant created Emerging Therapy Solutions® to help healthcare payers – including reinsurance and stop-loss payers, health plans and self-funded employers – manage the risks associated with high-cost therapies for rare and complex conditions. We offer a comprehensive suite of services for solid organ and bone marrow transplants, cell and gene therapies, and other highly specialized therapies.
To anticipate and understand what lies ahead for medical and underwriting services teams, we proactively monitor the latest developments for existing therapies and the clinical trial pipeline for near-term approvals. We curate and maintain a comprehensive Knowledge Center with extensive clinical education and data resources on these therapies and the rare and complex conditions being treated. We engage independent physician experts on standards of care for diagnosis, treatment, and review.
We provide trusted insight and expert services to payers, so they can maximize value for people in need of the newest complex and costly therapies.